Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF STOCK OPTION ACTIVITY (Details)

v3.22.1
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Weighted Average Exercise Price $ 0.66 $ 0.69
Number of Optioned Shares 1,640,000 1,575,000
Weighted Average Remaining Contractual Term in Years at beginning   3 years 9 months 25 days
Weighted Average Optioned Grant Date Fair Value at end $ 0.04 $ 0.04
Aggregate Intrinsic Value at beginning
Weighted Average Exercise Price, Granted $ 0.10
Number of Optioned Shares, Granted 90,000
Weighted Average Optioned Grant Date Fair Value, Granted $ 0.06
Weighted Average Exercise Price, Exercised
Number of Optioned Shares, Exercised
Weighted Average Optioned Grant Date Fair Value, Exercised
Weighted Average Exercise Price, Cancelled/expired $ 0.60 $ 0.54
Number of Optioned Shares , Forfeited/expired/canceled (50,000) (25,000)
Weighted Average Optioned Grant Date Fair Value, Cancelled/expired $ 0.19 $ 0.19
Weighted Average Remaining Contractual Term in Years 2 years 9 months 29 days  
Weighted Average Exercise Price $ 0.67 $ 0.66
Number of Optioned Shares 1,590,000 1,640,000
Weighted Average Remaining Contractual Term in Years, Vested and exercisable 1 year 10 months 28 days  
Weighted Average Optioned Grant Date Fair Value $ 0.04 $ 0.04
Aggregate Intrinsic Value at ending
Weighted Average Exercise Price, Vested and exercisable $ 0.67  
Number of Optioned Shares, Vested and exercisable 1,590,000  
Weighted Average Optioned Grant Date Fair Value, Vested and exercisable $ 0.04  
Aggregate Intrinsic Value Vested and exercisable